Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders

Provided herein are methods and compositions for treating or preventing metabolic disorders, such as obesity and diabetes. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin, or an inhibitory compound, such as nicotinamide


Year:
2007
Note:
Applicant(S): Sirtris Pharmaceuticals Inc [Us]
Other identifiers:
EPO Family ID: 37567655
EPO Family ID: 37492426
EPO Family ID: 36678263
EPO Family ID: 37307152
EPO Family ID: 38194679
EPO Family ID: 37054195
EPO Family ID: 37054169
EPO Family ID: 39892163
Laboratories:




 Record created 2009-04-21, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)